Decoding Spliceosome Inhibition: How New Molecules Combat Aberrant Exon Skipping
Explore how scientists are targeting SF3B1 within the spliceosome to correct massive aberrant exon skipping. This article breaks down the research, its implications, and what it means for future therapies.